Ticker ACER – Acer Therapeutics – sales, description, marketcap – Tickerday.com

ACER

Acer Therapeutics

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 35.98M; Volume: 370.88K; AvgVol 3m: 473.70K; Beta: 1.61;

Cost estimate:

P/E: –; EPS: -2.08; EPS growth quarter/prev quarter: 49.10%;

EPS growth this year: -17.20%; EPS growth past 5 years: 42.10%;

EPS ttm: -2.08;

P/S: ; P/B: 2.70; P/Cashflow: 6.25; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -108.40%; ROE – return on equity: -127.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 16.80%; Insider Transactions:11.79%;

Institutional Ownership: 39.40%; Institutional Transactions: -5.85%;

Data update: 07.10.2020.